Sol-Gel Technologies SLGL
NASDAQ SLGL
$69.96 -0.14 (-0.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

Sol-Gel Technologies (SLGL) Other Accumulated Expenses (2017 - 2025)

Sol-Gel Technologies (SLGL) posted quarterly Other Accumulated Expenses of $3.3 million for Q2 2025, down 20.23% year-over-year from $4.1 million in Q2 2024, and down 7.86% quarter-over-quarter from $3.6 million in Q4 2024.

Analysis

Sol-Gel Technologies (SLGL) Other Accumulated Expenses (2017 - 2025) Analysis & Trends

Sol-Gel Technologies (SLGL) has reported Other Accumulated Expenses for 8 consecutive years, with $3.3 million the latest figure, recorded in Q2 2025.

  • In Q2 2025, Other Accumulated Expenses fell 20.23% year-over-year to $3.3 million; the TTM figure through Jun 2025 stood at $3.3 million (down 20.23% YoY), while the FY2024 annual figure was $3.6 million, down 8.44% from the prior year.
  • Other Accumulated Expenses eased to $3.3 million in Q2 2025 per SLGL's latest filing, from $3.6 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $10.1 million in Q4 2021 and bottomed at $1.7 million in Q2 2022.
  • Historically, Other Accumulated Expenses has averaged $4.1 million across 5 years, with a median of $3.6 million in 2024.
  • Annual changes were most pronounced in 2022 — Other Accumulated Expenses tumbled 76.74% — and 2023, when it surged 186.84%.
  • Sol-Gel Technologies' Other Accumulated Expenses stood at $10.1 million in 2021, then sank by 76.74% to $2.4 million in 2022, then surged by 66.14% to $3.9 million in 2023, then retreated by 8.44% to $3.6 million in 2024, then fell by 7.86% to $3.3 million in 2025.
  • Business Quant data shows SLGL's Other Accumulated Expenses at $3.3 million in Q2 2025, $3.6 million in Q4 2024, and $4.1 million in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Sol-Gel Technologies 194.01 Mn 146.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 3.31 Mn
Dec 31, 2024 3.59 Mn
Jun 30, 2024 4.15 Mn
Dec 31, 2023 3.92 Mn
Jun 30, 2023 4.77 Mn
Dec 31, 2022 2.36 Mn
Jun 30, 2022 1.66 Mn
Dec 31, 2021 10.15 Mn
Jun 30, 2021 3.16 Mn
Dec 31, 2020 4.09 Mn
Dec 31, 2018 43,000.00
Dec 31, 2017 46,000.00